{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:37Z","timestamp":1761518917725,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.canrad.2009.02.008","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T04:31:47Z","timestamp":1242621107000},"page":"276-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["\u00c9valuation monocentrique de la tol\u00e9rance de l\u2019association concomitante de trastuzumab et de radioth\u00e9rapie"],"prefix":"10.1016","volume":"13","author":[{"given":"Y.-M.","family":"Kirova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Caussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Savignoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tournat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Pierga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Bollet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2009.02.008_bib1","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.ijrobp.2008.06.970","article-title":"Radiation treatments may contribute to the development of cardiac dysfunction in breast cancer patients treated with chemotherapy and trastuzumab","volume":"72","author":"Alm En-Din","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdn029","article-title":"Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: Acute toxicity analyses from the French multicentric study","volume":"19","author":"Belkacemi","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2009.02.008_bib3","first-page":"266","article-title":"Potential risk and benefit of the combination of trastuzumab to chemotherapy and radiation therapy in non-metastatic breast cancer","volume":"11","author":"Belkacemi","year":"2007","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2009.02.008_bib4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ijrobp.2005.07.097","article-title":"Concurrent Trastuzumab and radiation therapy (RT) in the adjuvant treatment of breast cancer","volume":"63","author":"Bellon","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1259\/bjr\/23839243","article-title":"Breast radiotherapy in women with pectus excavatum (funnel chest): Is the lateral decubitus technique an answer? A dosimetric study","volume":"79","author":"Bollet","year":"2006","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2009.02.008_bib6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2004.08.051","article-title":"Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation","volume":"61","author":"Campana","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib7","doi-asserted-by":"crossref","unstructured":"Castro Pena P, Kirova Y, Campana F, Dendale R, Bollet MA, Fournier-Bidoz N, et al. Anatomical, Clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Br J Radiol 2009:doi:10.1259\/bjr\/96865511.","DOI":"10.1259\/bjr\/96865511"},{"key":"10.1016\/j.canrad.2009.02.008_bib8","doi-asserted-by":"crossref","unstructured":"Chargari C, Fromantin I, Kirova Y. Int\u00e9r\u00eat des applications cutan\u00e9es en cours de radioth\u00e9rapie pour la pr\u00e9vention et le traitement des \u00e9pith\u00e9lites radio-induites. Cancer Radiother 2009:doi:10.1016\/j.canrad.2009.04.003.","DOI":"10.1016\/j.canrad.2009.04.003"},{"key":"10.1016\/j.canrad.2009.02.008_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.patbio.2008.03.009","article-title":"Diagnosis of HER2 gene amplification in breast carcinoma","volume":"56","author":"Couturier","year":"2008","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.canrad.2009.02.008_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.canrad.2009.02.008_bib11","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2009.02.008_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/jco.2006.24.18_suppl.523","article-title":"Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: Toxicity data from North Central Cancer Treatment Group Phase III trial N9831","volume":"24","author":"Halyard","year":"2006","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1016\/j.canrad.2009.02.008_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.canrad.2008.07.016","article-title":"Irradiation of lymph nodes areas in breast cancer","volume":"12","author":"Hennequin","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2009.02.008_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(00)00152-3","article-title":"Cardiac and lung complication probabilities after breast cancer irradiation","volume":"55","author":"Hurkmans","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.02.008_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa053028","article-title":"Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer","volume":"354","author":"Joensuu","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.canrad.2009.02.008_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ijrobp.2007.05.007","article-title":"Postmastectomy electron beam chest wall irradiation in women with breast cancer: A clinical step toward conformal electron therapy","volume":"69","author":"Kirova","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2007.12.059","article-title":"How to boost the breast tumor bed? A Multidisciplinary Approach in eight steps","volume":"72","author":"Kirova","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2006.05.014","article-title":"CT-scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning","volume":"79","author":"Kirova","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2009.02.008_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0360-3016(02)03741-0","article-title":"The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation","volume":"54","author":"Kong","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2009.02.008_bib20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejca.2006.11.015","article-title":"Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes","volume":"43","author":"Musat","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2009.02.008_bib21","first-page":"1347","article-title":"Monoclonal antibody to HER-2\/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene","volume":"59","author":"Pietras","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2009.02.008_bib22","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2009.02.008_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.canrad.2009.02.008_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2009.02.008_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","article-title":"2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial","volume":"369","author":"Smith","year":"2007","journal-title":"Lancet"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321809000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:15:23Z","timestamp":1761135323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321809000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1278321809000432"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2009.02.008","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9valuation monocentrique de la tol\u00e9rance de l\u2019association concomitante de trastuzumab et de radioth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2009.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}